YME1L depletion, using the shRNA strategy or the CRISPR/Cas9 gene editing method, disrupted mitochondrial function in glioma cells, causing mitochondrial depolarization, reactive oxygen species production and lipid peroxidation, leading to reduced cell viability, proliferation and migration of glioma cells [24]. Here, YME1L1 is linked to central nervous system cancer.